메뉴 건너뛰기




Volumn 94, Issue 11, 2015, Pages 1797-1806

Transfusion dependency at diagnosis and transfusion intensity during initial chemotherapy are associated with poorer outcomes in adult acute myeloid leukemia

Author keywords

Acute myeloid leukemia; Chemotherapy; Prognosis; Transfusion dependency; Transfusion intensity

Indexed keywords

ANTHRAQUINONE; CYTARABINE; HEMOGLOBIN; THROMBOCYTE CONCENTRATE; ANTINEOPLASTIC AGENT;

EID: 84941995370     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-015-2456-2     Document Type: Article
Times cited : (11)

References (46)
  • 1
    • 77449159028 scopus 로고    scopus 로고
    • Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
    • PID: 19880497
    • Döhner H, Estey EH, Amadori S et al (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115:453–474
    • (2010) Blood , vol.115 , pp. 453-474
    • Döhner, H.1    Estey, E.H.2    Amadori, S.3
  • 2
    • 33751267902 scopus 로고    scopus 로고
    • Acute myeloid leukaemia
    • PID: 17126723
    • Estey E, Döhner H (2006) Acute myeloid leukaemia. Lancet 368:1894–1907
    • (2006) Lancet , vol.368 , pp. 1894-1907
    • Estey, E.1    Döhner, H.2
  • 4
    • 0032188805 scopus 로고    scopus 로고
    • The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial
    • COI: 1:CAS:528:DyaK1cXmsVKnsrw%3D, PID: 9746770
    • Grimwade D, Walker H, Oliver F et al (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 92:2322–2333
    • (1998) Blood , vol.92 , pp. 2322-2333
    • Grimwade, D.1    Walker, H.2    Oliver, F.3
  • 5
    • 0028898585 scopus 로고
    • Immunologic effects of blood transfusion
    • COI: 1:STN:280:DyaK2M3ivFagug%3D%3D, PID: 7713588
    • Tartter PI (1995) Immunologic effects of blood transfusion. Immunol Invest 24:277–288
    • (1995) Immunol Invest , vol.24 , pp. 277-288
    • Tartter, P.I.1
  • 6
    • 0026504855 scopus 로고
    • Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system
    • COI: 1:STN:280:DyaK387jvF2gtA%3D%3D, PID: 1736014
    • Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W (1992) Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 6:52–59
    • (1992) Leukemia , vol.6 , pp. 52-59
    • Aul, C.1    Gattermann, N.2    Heyll, A.3    Germing, U.4    Derigs, G.5    Schneider, W.6
  • 7
    • 34548219420 scopus 로고    scopus 로고
    • Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes
    • PID: 17687155
    • Malcovati L, Germing U, Kuendgen A et al (2007) Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 25:3503–3510
    • (2007) J Clin Oncol , vol.25 , pp. 3503-3510
    • Malcovati, L.1    Germing, U.2    Kuendgen, A.3
  • 8
    • 77954658029 scopus 로고    scopus 로고
    • WHO-defined ‘myelodysplastic syndrome with isolated del(5q)’ in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL, and IDH mutations
    • COI: 1:CAS:528:DC%2BC3cXovFKmsL4%3D, PID: 20485371
    • Patnaik MM, Lasho TL, Finke CM et al (2010) WHO-defined ‘myelodysplastic syndrome with isolated del(5q)’ in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL, and IDH mutations. Leukemia 24:1283–1289
    • (2010) Leukemia , vol.24 , pp. 1283-1289
    • Patnaik, M.M.1    Lasho, T.L.2    Finke, C.M.3
  • 9
    • 79951888693 scopus 로고    scopus 로고
    • Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support
    • PID: 21328437
    • Pereira A, Nomdedeu M, Aguilar JL et al (2011) Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support. Am J Hematol 86:245–250
    • (2011) Am J Hematol , vol.86 , pp. 245-250
    • Pereira, A.1    Nomdedeu, M.2    Aguilar, J.L.3
  • 10
    • 78650973404 scopus 로고    scopus 로고
    • Prognostic relevance of anemia and transfusion dependency in myelodysplastic syndromes and primary myelofibrosis
    • PID: 21193428
    • Pardanani A, Tefferi A (2011) Prognostic relevance of anemia and transfusion dependency in myelodysplastic syndromes and primary myelofibrosis. Haematologica 96:8–10
    • (2011) Haematologica , vol.96 , pp. 8-10
    • Pardanani, A.1    Tefferi, A.2
  • 11
    • 63849328927 scopus 로고    scopus 로고
    • New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
    • COI: 1:CAS:528:DC%2BD1MXktFWnsLc%3D, PID: 18988864
    • Cervantes F, Dupriez B, Pereira A et al (2009) New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood 113:2895–2901
    • (2009) Blood , vol.113 , pp. 2895-2901
    • Cervantes, F.1    Dupriez, B.2    Pereira, A.3
  • 12
    • 84904339077 scopus 로고    scopus 로고
    • Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia
    • Le Jeune C, Bertoli S, Elhamri M et al (2014) Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia. Leuk Lymph 55:855–862
    • (2014) Leuk Lymph , vol.55 , pp. 855-862
    • Le Jeune, C.1    Bertoli, S.2    Elhamri, M.3
  • 13
    • 84555206702 scopus 로고    scopus 로고
    • Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making?
    • COI: 1:CAS:528:DC%2BC3MXhtlGrt77J
    • Thomas X, Chelghoum Y, Cannas G et al (2011) Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making? Clin Lymph Myel Leuk 11:342–349
    • (2011) Clin Lymph Myel Leuk , vol.11 , pp. 342-349
    • Thomas, X.1    Chelghoum, Y.2    Cannas, G.3
  • 14
    • 1542753559 scopus 로고    scopus 로고
    • Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
    • PID: 14673054
    • Cheson BD, Bennett JM, Kopecky KJ et al (2003) Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 21:4642–4649
    • (2003) J Clin Oncol , vol.21 , pp. 4642-4649
    • Cheson, B.D.1    Bennett, J.M.2    Kopecky, K.J.3
  • 15
    • 79958858626 scopus 로고    scopus 로고
    • Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia?
    • PID: 21671359
    • Jaime-Perez JC, Colunga-Pedraza PR, Gomez-Almaguer DG (2011) Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia? Pediatr Blood Cancer 57:217–223
    • (2011) Pediatr Blood Cancer , vol.57 , pp. 217-223
    • Jaime-Perez, J.C.1    Colunga-Pedraza, P.R.2    Gomez-Almaguer, D.G.3
  • 16
    • 0028283987 scopus 로고
    • Transfusions and risk of failure in childhood acute lymphoblastic leukemia
    • COI: 1:STN:280:DyaK2czgvFejug%3D%3D, PID: 8035615
    • Freiberg A, Hancock M, Kunkel K (1994) Transfusions and risk of failure in childhood acute lymphoblastic leukemia. Leukemia 8:1220–1223
    • (1994) Leukemia , vol.8 , pp. 1220-1223
    • Freiberg, A.1    Hancock, M.2    Kunkel, K.3
  • 17
    • 32144431895 scopus 로고    scopus 로고
    • Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making
    • PID: 16186598
    • Malcovati L, Porta MG, Pascutto C et al (2005) Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol 23:7594–7603
    • (2005) J Clin Oncol , vol.23 , pp. 7594-7603
    • Malcovati, L.1    Porta, M.G.2    Pascutto, C.3
  • 18
    • 53149113768 scopus 로고    scopus 로고
    • Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
    • COI: 1:CAS:528:DC%2BD1cXhtFyls7rM, PID: 18618511
    • Kantarjian H, O’Brien S, Ravandi F et al (2008) Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer 113:1351–1361
    • (2008) Cancer , vol.113 , pp. 1351-1361
    • Kantarjian, H.1    O’Brien, S.2    Ravandi, F.3
  • 19
    • 74049158614 scopus 로고    scopus 로고
    • Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis—prognostic relevance is dependent of IPSS or karyotype
    • Tefferi A, Siragusa S, Hussein K et al (2009) Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis—prognostic relevance is dependent of IPSS or karyotype. Am J Hematol 85:14–17
    • (2009) Am J Hematol , vol.85 , pp. 14-17
    • Tefferi, A.1    Siragusa, S.2    Hussein, K.3
  • 20
    • 78650989990 scopus 로고    scopus 로고
    • Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of International Prognostic Scoring System and Dynamic International Prognostic Scoring System
    • PID: 20884708
    • Elena C, Passamonti F, Rumi E et al (2011) Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of International Prognostic Scoring System and Dynamic International Prognostic Scoring System. Haematologica 96:167–170
    • (2011) Haematologica , vol.96 , pp. 167-170
    • Elena, C.1    Passamonti, F.2    Rumi, E.3
  • 21
    • 77950352432 scopus 로고    scopus 로고
    • A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
    • COI: 1:CAS:528:DC%2BC3cXjtlGisL4%3D, PID: 20008785
    • Passamonti F, Cervantes F, Vannucchi AM et al (2010) A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood 115:1703–1708
    • (2010) Blood , vol.115 , pp. 1703-1708
    • Passamonti, F.1    Cervantes, F.2    Vannucchi, A.M.3
  • 22
    • 49149112388 scopus 로고    scopus 로고
    • Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts
    • COI: 1:CAS:528:DC%2BD1cXhtVGls7jN, PID: 18442062
    • Chee CE, Steensma DP, Wu W, Hanson CA, Tefferi A (2008) Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts. Am J Hematol 83:611–613
    • (2008) Am J Hematol , vol.83 , pp. 611-613
    • Chee, C.E.1    Steensma, D.P.2    Wu, W.3    Hanson, C.A.4    Tefferi, A.5
  • 23
    • 65649110882 scopus 로고    scopus 로고
    • Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not
    • COI: 1:CAS:528:DC%2BD1MXmtFelsrg%3D, PID: 19396855
    • Tefferi A, Mesa RA, Pardanani A et al (2009) Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not. Am J Hematol 84:265–267
    • (2009) Am J Hematol , vol.84 , pp. 265-267
    • Tefferi, A.1    Mesa, R.A.2    Pardanani, A.3
  • 24
    • 34848892687 scopus 로고    scopus 로고
    • Transfusion-related immunomodulation (TRIM): an update
    • PID: 17804128
    • Vamvakas EC, Blajchman MA (2007) Transfusion-related immunomodulation (TRIM): an update. Blood Rev 21:327–348
    • (2007) Blood Rev , vol.21 , pp. 327-348
    • Vamvakas, E.C.1    Blajchman, M.A.2
  • 25
    • 0033642420 scopus 로고    scopus 로고
    • Immunomodulation by blood transfusions
    • PID: 10938968
    • Roelen DL, van Rood JJ, Brand A et al (2000) Immunomodulation by blood transfusions. Vox Sang 78:273–275
    • (2000) Vox Sang , vol.78 , pp. 273-275
    • Roelen, D.L.1    van Rood, J.J.2    Brand, A.3
  • 26
    • 0027968516 scopus 로고
    • Biologic effects of leukocytes present in transfused cellular blood products
    • COI: 1:STN:280:DyaK2czmt1aitQ%3D%3D, PID: 8080981
    • Bordin JO, Heddle NM, Blajchman MA (1994) Biologic effects of leukocytes present in transfused cellular blood products. Blood 84:1703–1721
    • (1994) Blood , vol.84 , pp. 1703-1721
    • Bordin, J.O.1    Heddle, N.M.2    Blajchman, M.A.3
  • 27
    • 0035434162 scopus 로고    scopus 로고
    • Arginase release from red blood cells: possible link in transfusion induced immune suppression?
    • COI: 1:STN:280:DC%2BD3MvmtlOisA%3D%3D, PID: 11508862
    • Prins HA, Houdijk AP, Nijveldt RJ et al (2001) Arginase release from red blood cells: possible link in transfusion induced immune suppression? Shock 16:113–115
    • (2001) Shock , vol.16 , pp. 113-115
    • Prins, H.A.1    Houdijk, A.P.2    Nijveldt, R.J.3
  • 28
    • 62349142604 scopus 로고    scopus 로고
    • An introduction to chemokines and their roles in transfusion medicine
    • COI: 1:CAS:528:DC%2BD1MXkvVKisLg%3D, PID: 19076338
    • Davenport RD (2009) An introduction to chemokines and their roles in transfusion medicine. Vox Sang 96:183–198
    • (2009) Vox Sang , vol.96 , pp. 183-198
    • Davenport, R.D.1
  • 29
    • 33746492285 scopus 로고    scopus 로고
    • Release of potential immunomodulatory factors during platelet storage
    • COI: 1:CAS:528:DC%2BD28XnsFarur4%3D, PID: 16836566
    • Cognasse F, Boussoulade F, Chavarin P et al (2006) Release of potential immunomodulatory factors during platelet storage. Transfusion 46:1184–1189
    • (2006) Transfusion , vol.46 , pp. 1184-1189
    • Cognasse, F.1    Boussoulade, F.2    Chavarin, P.3
  • 30
    • 0029920586 scopus 로고    scopus 로고
    • Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays
    • COI: 1:CAS:528:DyaK28XjtVyksbk%3D, PID: 8611466
    • Wadhwa M, Seghatchian MJ, Lubenko A et al (1996) Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays. Br J Haematol 93:225–234
    • (1996) Br J Haematol , vol.93 , pp. 225-234
    • Wadhwa, M.1    Seghatchian, M.J.2    Lubenko, A.3
  • 31
    • 0031753239 scopus 로고    scopus 로고
    • Bioactive substances in buffy-coat-derived platelet pools stored in platelet-additive solutions
    • COI: 1:CAS:528:DyaK1cXnvFOisb0%3D, PID: 9827918
    • Edvardsen L, Taaning E, Mynster T, Hvolris J, Drachman O, Nielsen HJ (1998) Bioactive substances in buffy-coat-derived platelet pools stored in platelet-additive solutions. Br J Haematol 103:445–448
    • (1998) Br J Haematol , vol.103 , pp. 445-448
    • Edvardsen, L.1    Taaning, E.2    Mynster, T.3    Hvolris, J.4    Drachman, O.5    Nielsen, H.J.6
  • 32
    • 0036841640 scopus 로고    scopus 로고
    • CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts
    • COI: 1:CAS:528:DC%2BD38XosFCjsrY%3D, PID: 12423681
    • Aldinucci D, Poletto D, Nanni P et al (2002) CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts. Exp Hematol 30:1283–1292
    • (2002) Exp Hematol , vol.30 , pp. 1283-1292
    • Aldinucci, D.1    Poletto, D.2    Nanni, P.3
  • 33
    • 0033861859 scopus 로고    scopus 로고
    • T-cell subsets (Th1 versus Th2)
    • COI: 1:CAS:528:DC%2BD3cXlvVSkur4%3D, PID: 10923599
    • Romagnani S (2000) T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 85:9–18
    • (2000) Ann Allergy Asthma Immunol , vol.85 , pp. 9-18
    • Romagnani, S.1
  • 34
    • 84891493506 scopus 로고    scopus 로고
    • The evolving art of hematopoietic stem cell transplantation: translational research in post-transplant immune reconstitution and immunosuppression
    • COI: 1:CAS:528:DC%2BC3sXhvFelsr7K, PID: 24242818
    • Komanduri KV, Wieder ED, Benjamin CL, Levy RB (2013) The evolving art of hematopoietic stem cell transplantation: translational research in post-transplant immune reconstitution and immunosuppression. Immunol Res 57:140–150
    • (2013) Immunol Res , vol.57 , pp. 140-150
    • Komanduri, K.V.1    Wieder, E.D.2    Benjamin, C.L.3    Levy, R.B.4
  • 35
    • 84887817115 scopus 로고    scopus 로고
    • Clinical strategies to enhance thymic recovery after allogeneic hematopoietic stem cell transplantation
    • COI: 1:CAS:528:DC%2BC3sXhs12lsbnK
    • Velardi E, Dudakov JA, van den Brink MR (2013) Clinical strategies to enhance thymic recovery after allogeneic hematopoietic stem cell transplantation. Immunol Let 155:31–35
    • (2013) Immunol Let , vol.155 , pp. 31-35
    • Velardi, E.1    Dudakov, J.A.2    van den Brink, M.R.3
  • 36
    • 23844525447 scopus 로고    scopus 로고
    • Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt
    • PID: 16086785, discussion 39S-40S
    • Blumberg N (2005) Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 45:33S–39S, discussion 39S-40S
    • (2005) Transfusion , vol.45 , pp. 33-39
    • Blumberg, N.1
  • 37
    • 0030060765 scopus 로고    scopus 로고
    • Blood transfusion-induced immunomodulation
    • COI: 1:CAS:528:DyaK28XhtFGkurc%3D, PID: 8712400
    • Landers DF, Hill GE, Wong KC et al (1996) Blood transfusion-induced immunomodulation. Anesth Analg 82:187–204
    • (1996) Anesth Analg , vol.82 , pp. 187-204
    • Landers, D.F.1    Hill, G.E.2    Wong, K.C.3
  • 38
    • 0032521823 scopus 로고    scopus 로고
    • Transfusion-induced immunomodulation following cancer surgery: fact or fiction?
    • COI: 1:CAS:528:DyaK1cXivFGjsbc%3D, PID: 9554439
    • Lapierre V, Auperin A, Tiberghien P (1998) Transfusion-induced immunomodulation following cancer surgery: fact or fiction? J Natl Cancer Inst 90:573–580
    • (1998) J Natl Cancer Inst , vol.90 , pp. 573-580
    • Lapierre, V.1    Auperin, A.2    Tiberghien, P.3
  • 39
    • 84897537450 scopus 로고    scopus 로고
    • Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis
    • COI: 1:CAS:528:DC%2BC2cXmtVaqsLo%3D, PID: 24691607
    • Rohde JM, Dimcheff DE, Blumberg N et al (2014) Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 311:1317–1326
    • (2014) JAMA , vol.311 , pp. 1317-1326
    • Rohde, J.M.1    Dimcheff, D.E.2    Blumberg, N.3
  • 40
    • 0027467636 scopus 로고
    • Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells
    • COI: 1:STN:280:DyaK3s3hsVSnsQ%3D%3D, PID: 8461473
    • Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP (1993) Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 81:1880–1882
    • (1993) Blood , vol.81 , pp. 1880-1882
    • Blajchman, M.A.1    Bardossy, L.2    Carmen, R.3    Sastry, A.4    Singal, D.P.5
  • 41
    • 0022513856 scopus 로고
    • Association between transfusion of whole blood and recurrence of cancer
    • COI: 1:STN:280:DyaL2s%2FgtFWmtQ%3D%3D
    • Blumberg N, Heal JM, Murphy P et al (1986) Association between transfusion of whole blood and recurrence of cancer. Br Med J 293:530–533
    • (1986) Br Med J , vol.293 , pp. 530-533
    • Blumberg, N.1    Heal, J.M.2    Murphy, P.3
  • 42
    • 84864042696 scopus 로고    scopus 로고
    • Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
    • PID: 22513904
    • Carson JL, Carless PA, Hebert PC (2012) Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 4:CD002042
    • (2012) Cochrane Database Syst Rev , vol.4 , pp. 002042
    • Carson, J.L.1    Carless, P.A.2    Hebert, P.C.3
  • 43
    • 1842715067 scopus 로고    scopus 로고
    • Feasibility of a restrictive red-cell transfusion policy for patients treated with chemotherapy for acute myeloid leukaemia
    • COI: 1:STN:280:DC%2BD2c7lt1CitA%3D%3D, PID: 15043591
    • Jansen AJ, Caljouw MA, Hop WC, van Rhenen DJ, Schipperus MR (2004) Feasibility of a restrictive red-cell transfusion policy for patients treated with chemotherapy for acute myeloid leukaemia. Transfus Med 14:33–38
    • (2004) Transfus Med , vol.14 , pp. 33-38
    • Jansen, A.J.1    Caljouw, M.A.2    Hop, W.C.3    van Rhenen, D.J.4    Schipperus, M.R.5
  • 44
    • 84892980199 scopus 로고    scopus 로고
    • Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review
    • COI: 1:CAS:528:DC%2BC3sXhvFyru7jO, PID: 24331453
    • Salpeter SR, Buckley JS, Chatterjee S (2014) Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med 127:124–131
    • (2014) Am J Med , vol.127 , pp. 124-131
    • Salpeter, S.R.1    Buckley, J.S.2    Chatterjee, S.3
  • 45
    • 84864758825 scopus 로고    scopus 로고
    • Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation
    • PID: 22592695
    • Estcourt L, Stanworth S, Doree C et al (2012) Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 5:CD004269
    • (2012) Cochrane Database Syst Rev , vol.5 , pp. 004269
    • Estcourt, L.1    Stanworth, S.2    Doree, C.3
  • 46
    • 84877624763 scopus 로고    scopus 로고
    • A no-prophylaxis platelet-transfusion strategy for hematologic cancers
    • COI: 1:CAS:528:DC%2BC3sXnvVWls7k%3D, PID: 23656642
    • Stanworth SJ, Estcourt L, Powter G et al (2013) A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 368:1771–1780
    • (2013) N Engl J Med , vol.368 , pp. 1771-1780
    • Stanworth, S.J.1    Estcourt, L.2    Powter, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.